Trebicka J - Search Results

1

CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt.

Berres ML, Asmacher S, Lehmann J, Jansen C, Görtzen J, Klein S, Meyer C, Strunk HM, Fimmers R, Tacke F, Strassburg CP, Trautwein C, Sauerbruch T, Wasmuth HE, Trebicka J. Berres ML, et al. Among authors: trebicka j. J Hepatol. 2015 Feb;62(2):332-9. doi: 10.1016/j.jhep.2014.09.032. Epub 2014 Oct 17. J Hepatol. 2015. PMID: 25457205

2

Acute haemodynamic effects of losartan in anaesthetized cirrhotic rats.

Heller J, Shiozawa T, Trebicka J, Hennenberg M, Schepke M, Neef M, Sauerbruch T. Heller J, et al. Among authors: trebicka j. Eur J Clin Invest. 2003 Nov;33(11):1006-12. doi: 10.1046/j.1365-2362.2003.01251.x. Eur J Clin Invest. 2003. PMID: 14636305

3

Vascular, hemodynamic and renal effects of low-dose losartan in rats with secondary biliary cirrhosis.

Heller J, Trebicka J, Shiozawa T, Schepke M, Neef M, Hennenberg M, Sauerbruch T. Heller J, et al. Among authors: trebicka j. Liver Int. 2005 Jun;25(3):657-66. doi: 10.1111/j.1478-3231.2005.01053.x. Liver Int. 2005. PMID: 15910503

4

Intrahepatic upregulation of RhoA and Rho-kinase signalling contributes to increased hepatic vascular resistance in rats with secondary biliary cirrhosis.

Zhou Q, Hennenberg M, Trebicka J, Jochem K, Leifeld L, Biecker E, Sauerbruch T, Heller J. Zhou Q, et al. Among authors: trebicka j. Gut. 2006 Sep;55(9):1296-305. doi: 10.1136/gut.2005.081059. Epub 2006 Feb 21. Gut. 2006. PMID: 16492715 Free PMC article.

5

Defective RhoA/Rho-kinase signaling contributes to vascular hypocontractility and vasodilation in cirrhotic rats.

Hennenberg M, Biecker E, Trebicka J, Jochem K, Zhou Q, Schmidt M, Jakobs KH, Sauerbruch T, Heller J. Hennenberg M, et al. Among authors: trebicka j. Gastroenterology. 2006 Mar;130(3):838-54. doi: 10.1053/j.gastro.2005.11.029. Gastroenterology. 2006. PMID: 16530523

6

Portal hypertension and nodular regenerative hyperplasia in a patient with celiac disease.

Biecker E, Trebicka J, Fischer HP, Sauerbruch T, Lammert F. Biecker E, et al. Among authors: trebicka j. Z Gastroenterol. 2006 May;44(5):395-8. doi: 10.1055/s-2006-926581. Z Gastroenterol. 2006. PMID: 16688657

7

Vascular dysfunction in human and rat cirrhosis: role of receptor-desensitizing and calcium-sensitizing proteins.

Hennenberg M, Trebicka J, Biecker E, Schepke M, Sauerbruch T, Heller J. Hennenberg M, et al. Among authors: trebicka j. Hepatology. 2007 Feb;45(2):495-506. doi: 10.1002/hep.21502. Hepatology. 2007. PMID: 17256744

8

Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthase.

Trebicka J, Hennenberg M, Laleman W, Shelest N, Biecker E, Schepke M, Nevens F, Sauerbruch T, Heller J. Trebicka J, et al. Hepatology. 2007 Jul;46(1):242-53. doi: 10.1002/hep.21673. Hepatology. 2007. PMID: 17596891

9

Treatment of bile duct-ligated rats with the nitric oxide synthase transcription enhancer AVE 9488 ameliorates portal hypertension.

Biecker E, Trebicka J, Kang A, Hennenberg M, Sauerbruch T, Heller J. Biecker E, et al. Among authors: trebicka j. Liver Int. 2008 Mar;28(3):331-8. doi: 10.1111/j.1478-3231.2008.01664.x. Liver Int. 2008. PMID: 18290775

10

Hemodynamic effects of urotensin II and its specific receptor antagonist palosuran in cirrhotic rats.

Trebicka J, Leifeld L, Hennenberg M, Biecker E, Eckhardt A, Fischer N, Pröbsting AS, Clemens C, Lammert F, Sauerbruch T, Heller J. Trebicka J, et al. Hepatology. 2008 Apr;47(4):1264-76. doi: 10.1002/hep.22170. Hepatology. 2008. PMID: 18318439

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

472 results

Search Page

Filters